1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
6 
combinant DXA activity which the Secretary finds does not 
present a significant risk to health or the environment. Each 
such order shall be published in the Federal Register together 
with a statement of the basis for the order. 
(c) (1) Each entity which, on the date of the enact- 
ment of this Act, is responsible for the conduct of any 
recombinant DXA activity shall, in accordance with regula- 
tions promulgated under subsection (d) and before the ex- 
piration of ninety days from the date of the enactment of 
this Act, report in writing to the Secretary — 
( A ) such entity’s name, and 
(B) a description of such activity and an identifica- 
tion of the place or places in which it is being conducted, 
and 
(C) assurances satisfactory to the Secretary that 
such activity will be carried out in accordance with the 
applicable requirements of subsection (a) (1). 
(2) Each entity which is to be responsible for a 
recombinant DXA activity to be commenced during the 
period described in subsection (a) (1) shall upon the 
commencement of such activity report in writing to the 
Secretary such entity’s name, a description of such activity, 
an identification of the place or places in which such ac- 
tivity is to be conducted, and assurances satisfactory to the 
[Appendix B — 30] 
